XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Interim Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities:    
Net loss $ (9,678) $ (8,051)
Adjustments to reconcile net loss to net cash flows used in operating activities:    
Depreciation of property and equipment 37 65
Interest income and unrealized gains from marketable securities (282) (2)
Share-based compensation 821 1,067
Changes in assets and liabilities:    
Prepaid expenses and other assets (175) (274)
Other payables and accrued liabilities (11) (176)
Insurance recovery related to legal settlement and legal expenses received in cash 1,335
Legal settlement paid in cash (1,100)
Net cash flows used in operating activities (9,288) (7,136)
Investing activities:    
Purchases of property and equipment (35) (18)
Purchases of marketable securities (79,918) (5,120)
Proceeds from sales of marketable securities 9,102 2,680
Proceeds from maturities of marketable securities 2,500
Net cash flows (used in) provided by investing activities (70,851) 42
Financing activities:    
Issuance of common stock and warrants, net 83,733 5,104
Exercise of options 1
Net cash flows provided by financing activities 83,734 5,104
Increase (decrease) in cash, cash equivalents and restricted cash 3,595 (1,990)
Cash, cash equivalents and restricted cash at beginning of period 3,163 2,517
Cash, cash equivalents and restricted cash at end of period 6,758 527
Supplemental disclosure of non-cash investing and financing activities:    
Right-of-use assets obtained in exchange for lease liabilities 893 37
Issuance expenses not paid 153
Legal settlement settled through issuance of common stock 1,111
Accrued bonus settled through grant of stock-option awards 76
Deferred issuance expenses 30
Supplemental disclosure of cash flow information:    
Cash and cash equivalents 6,704 479
Restricted cash 54 48
Cash, cash equivalents and restricted cash $ 6,758 $ 527